婷婷综合色丁香五月_变态免费视频网站网站_亚洲v日韩v欧美高清在线观看_亚洲精品人妻中文字幕在线

首頁(yè) > 產(chǎn)品中心 > 有機(jī)化學(xué) > 胺類(lèi)衍生物

5-(4-氟苯基)-2-(1-甲基-乙基)-N,4-二聯(lián)苯-1-[2-[(2R,4R)-四氫-羥基-6-氧代-2H-吡喃-2-YL]乙基]-1H-吡咯-3-酸胺

Atorvastatin lactone

產(chǎn)品編號(hào).: A995031 CAS號(hào): 125995-03-1
分子式: C33H33N2O4F 分子量: 540.62452
純度: 98% MDL NO.:

中文名稱：5-(4-氟苯基)-2-(1-甲基-乙基)-N,4-二聯(lián)苯-1-[2-[(2R,4R)-四氫-羥基-6-氧代-2H-吡喃-2-YL]乙基]-1H-吡咯-3-酸胺
CAS號(hào)：125995-03-1
中文別名：阿托伐他汀內(nèi)酯;(4R,6R)-6-{2-[2-(4-氟苯基)-5-異丙基-3-苯基-4-(苯基氨基甲?；?吡咯-1-基]乙基}-4-羥基四氫-2H-吡喃-2-酮;5-(4-氟苯基)-2-(1-甲基-乙基)-N,4-二聯(lián)苯-1-[2-[(2R,4R)-四氫-羥基-6-氧代-2H-吡喃-2-yl]乙基]-1H-吡咯-3-羧酸胺鹽;阿伐他汀鈣內(nèi)酯;阿托伐他汀-D5內(nèi)酯;阿托伐他汀鈣雜質(zhì) D;阿托伐他汀鈣雜質(zhì)H(EP) 標(biāo)準(zhǔn)品;阿托伐他汀內(nèi)酯(阿托伐他汀EP雜質(zhì)H);阿托伐他汀內(nèi)酯標(biāo)準(zhǔn)品;阿托伐他汀中間體L-6;氨曲南-D5;直接蘭80;阿托伐他汀鈣雜質(zhì)H;5-(4-氟苯基)-1-[2-[(2R,4R)-4-羥基-6-氧代四氫-2H-吡喃-2-基]乙基]-2-異丙基-N,4-二苯基-1H-吡咯-3-甲酰胺;阿托伐他汀相關(guān)化合物H;阿托伐他汀內(nèi)脂;阿托伐他汀雜質(zhì)H;阿托伐他汀EP雜質(zhì)H;阿托伐他汀D5硫丹內(nèi)酯;阿托伐他汀鈣EP雜質(zhì)H;5-(4-氟苯基)-2-(1-甲基-乙基)-N,4-二聯(lián)苯-1-[2-[(2R,4R)-四氫-羥基-6-氧代-2H-吡喃-2-YL]乙基]-1H-吡咯-3-羧酸胺鹽
英文名稱：Atorvastatin lactone
英文別名：Atorvastatin lactone;(4R,6R)-6-{2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one;Atorvastatin Lactone L-6;ATORVASTATIN-D5 LACTONE;Atorvastatin EP Imp H;Atorvastatin EP Impurity H;Benzeneacetamide,a-cyano-4-methoxy;5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide;Lactone Impurity, 5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide;Atorvastatin Related Compound H;5-(4-Fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide;Atorvastatin d-Lactone;Atorvastatin Impurity H;(RS) Atorvastatin Lactone;Atorvastatin EPIMp H (USP RCH);Atorvastatin Calcium Impurity D;Diepoxide Atorvastatin Lactone Diepoxide;1-[2-[[(2R)-Tetrahydro-4β-hydroxy-6-oxo-2H-pyran]-2α-yl]ethyl]-5-(4-fluorophenyl)-2-isopropyl-4,N-diphenyl-1H-pyrrole-3-carboxamide;ATORVASTATIN LACTONE;Atorvastatin EP IMpurity H;ATORVASTATIN LACTONE [MI];MLS006010799;(2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1H-pyrrole-3-carboxamide;5-(4-fluorophenyl)-1-[2-((2R,4R)4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;5-(4-fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide;DTXSID90155033;5-(4-fluorophenyl)-1-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide;(2R-Trans)-5-(4-fluorophenyl)-2-(1-methyl -ethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo -2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide;(2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]1H-pyrrole-3-carboxamide;(2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide;5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran -2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;ATORVASTATIN .DELTA.-LACTONE;ATORVASTATIN CALCIUM IMPURITY H [EP IMPURITY];AKOS015896169;DTXCID4077524;5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;C33H33FN2O4;UNII-7876IL7J2N;5-(4-Fluoro-phenyl)-1-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;(2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide;J-005315;Q27074604;(2R-trans)-5-(4-fluorophenyl)-2-(1-methyl-ethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-o...
EINEC:
分子式：C33H33N2O4F
分子量：540.62452
搜索質(zhì)檢報(bào)告(COA)
搜索MSDS
已經(jīng)到最底了
批量搜索 關(guān)閉
批處理可以通過(guò)CAS號(hào)，CAS號(hào)，每行一個(gè)搜索
...

5-(4-氟苯基)-2-(1-甲基-乙基)-N,4-二聯(lián)苯-1-[2-[(2R,4R)-四氫-羥基-6-氧代-2H-吡喃-2-YL]乙基]-1H-吡咯-3-酸胺
Atorvastatin lactone;(4R,6R)-6-{2-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-4-hydroxytetrahydro-2H-pyran-2-one;Atorvastatin Lactone L-6;ATORVASTATIN-D5 LACTONE;Atorvastatin EP Imp H;Atorvastatin EP Impurity H;Benzeneacetamide,a-cyano-4-methoxy;5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide;Lactone Impurity, 5-(4-Fluorophenyl)-1-{2-[(2R, 4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide;Atorvastatin Related Compound H;5-(4-Fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide;Atorvastatin d-Lactone;Atorvastatin Impurity H;(RS) Atorvastatin Lactone;Atorvastatin EPIMp H (USP RCH);Atorvastatin Calcium Impurity D;Diepoxide Atorvastatin Lactone Diepoxide;1-[2-[[(2R)-Tetrahydro-4β-hydroxy-6-oxo-2H-pyran]-2α-yl]ethyl]-5-(4-fluorophenyl)-2-isopropyl-4,N-diphenyl-1H-pyrrole-3-carboxamide;ATORVASTATIN LACTONE;Atorvastatin EP IMpurity H;ATORVASTATIN LACTONE [MI];MLS006010799;(2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]-1H-pyrrole-3-carboxamide;5-(4-fluorophenyl)-1-[2-((2R,4R)4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;5-(4-fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide;DTXSID90155033;5-(4-fluorophenyl)-1-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-2-isopropyl-N,4-diphenyl-1H-pyrrole-3-carboxamide;(2R-Trans)-5-(4-fluorophenyl)-2-(1-methyl -ethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo -2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide;(2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-ethyl]1H-pyrrole-3-carboxamide;(2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide;5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran -2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;ATORVASTATIN .DELTA.-LACTONE;ATORVASTATIN CALCIUM IMPURITY H [EP IMPURITY];AKOS015896169;DTXCID4077524;5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;C33H33FN2O4;UNII-7876IL7J2N;5-(4-Fluoro-phenyl)-1-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide;(2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide;J-005315;Q27074604;(2R-trans)-5-(4-fluorophenyl)-2-(1-methyl-ethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-o...